Results 211 to 220 of about 346,022 (311)
Comment on Deeb et al.: interpretation of breath cannabinoids and implications for impairment. [PDF]
Olson A.
europepmc +1 more source
Abstract Oxidation of furfural (FF), a bio‐based platform chemical, was investigated using a range of iron‐, vanadium‐ and iron–zinc‐oxalates supported on silica gel (FeVOx@silica and FeZnOx@silica, respectively) as precursor for FeV@silica and FeZn@silica oxide catalysts and H2O2 as a green oxidant.
Alexander Pokutsa +2 more
wiley +1 more source
Revealing key biomarkers and molecular mechanisms associated with di(2-ethylhexyl) phthalate in skin cancer. [PDF]
Zhou H +9 more
europepmc +1 more source
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi +2 more
wiley +1 more source
Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard +11 more
wiley +1 more source
Model organism futures in precision toxicology: tracking the emergence of a research repertoire. [PDF]
Ankeny RA, Leonelli S.
europepmc +1 more source
Aim The aim of this study was to develop a novel workflow to identify human urine biomarkers for drugs of abuse and new psychoactive substances. Metabolites of amphetamine, cocaine, LSD, MDMA, methamphetamine, THC, MDMB‐CHMICA, and MDPPP were first identified in a zebrafish embryo (ZE) metabolism study followed by comparison to most abundant human ...
Simon K. Wellenberg +7 more
wiley +1 more source
From prediction to adaptation: rethinking the epistemic role of inhalation toxicology. [PDF]
Dekali S.
europepmc +1 more source
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source

